- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00943085
Early Family-Focused Treatment for Youth at Risk for Bipolar Disorder
Family-Focused Therapy as Early Treatment for Youth at Risk for Bipolar Disorder
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Early-onset bipolar disorder (BD) is a chronic, recurrent disorder that starts before age 18. In addition to the debilitating effects of BD, which include episodes of lethargic depression and exhausting mania, children and adolescents with BD often have co-occurring disorders, such as attention deficit hyperactivity disorder, conduct disorder, substance abuse disorders, and anxiety disorders. Early interventions may lead to better mental health by preventing BD from ever fully expressing itself. This study will test an early intervention for BD called family-focused treatment (FFT), which targets children and adolescents who are at risk for developing BD. FFT will include education about BD and training in communication strategies and problem-solving skills. It will focus on the family, because family environmental factors are related to the course and recurrence of BD. By reducing risk factors and teaching coping skills, FFT aims to prevent expression of BD, delay the onset or reduce the severity of manic episodes, and ensure that the first treatment received is appropriate.
Participation in this study will last 1 year and include three parts. In the first part, participating children and their families will complete research interviews and questionnaires about the child's mood, behavior, beliefs, and problems. Parent participants will also provide information on the family background of mood or anxiety problems. In the second part, participants will be randomly assigned to receive one of two treatments: FFT or brief educational treatment. Participants receiving FFT will complete 12 therapy sessions in which parents, children, and siblings learn how to cope with mood disorders, new ways to talk to each other, and strategies for solving family problems. FFT sessions will occur weekly for the first 8 weeks and then every other week for the next 8 weeks. Participants receiving brief educational treatment will complete diagnostic assessments and a 1-hour individualized feedback session, and they will be given a workbook about childhood mood disorders. A counselor will be available to all participants, in case of emergencies, for the full study year. All participants will also be provided with standard pharmacotherapy as needed. In the third part of the study, participants will complete follow-up assessments every 4 months for 1 year. Assessments will include interviews and questionnaires similar to those completed in the first part of the study.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Stanford, California, United States, 94304
- Stanford University School of Medicine, Lucile Packard Children's Hospital
-
-
Colorado
-
Boulder, Colorado, United States, 80309-0345
- University of Colorado, Boulder
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Has at least one biological parent or stepparent with whom the child or adolescent participant lives and who is willing to participate in family treatment
- Has a DSM-IV diagnosis of at least one of the following within the past 2 years : bipolar disorder not otherwise specified (BD-NOS), major depressive disorder (MDD), or cyclothymia
- If the main diagnosis is MDD, the depressive episode must have occurred within the past 2 years
- Has evidence of current significant affective symptoms, as determined by a score greater than 11 on the Young Mania Rating Scale within the last week or a score greater than 29 on the Child Depression Rating Scale-Revised within the last 2 weeks
- Not currently enrolled in family or marital therapy
- Has at least one biological parent or sibling with a verifiable diagnosis of bipolar disorder I or II
- Speaks English
Exclusion Criteria:
- Fully diagnosable bipolar disorder I or II
- Diagnosis of autism or pervasive developmental disorder
- Evidence of mental retardation, as defined by an intelligence quotient (IQ) less than 70
- Presence of comorbid neurologic diseases such as seizure disorder
- Substance or alcohol abuse or dependence disorders in the 4 months prior to study recruitment
- Evidence of a life-threatening eating disorder or other medical disorder that requires emergency medical treatment
- Has previously been treated with family-focused therapy
- Evidence of current sexual or physical abuse or domestic abuse between the adult partners
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Family-focused therapy
Participants will receive family-focused therapy.
|
12 therapy sessions involving the at-risk child or adolescent, parents, and available siblings.
Therapy will include psychoeducation about mood disorders, communication enhancement training, and problem-solving skills training.
Ongoing medication management from a study psychiatrist will be available.
Other Names:
|
Active Comparator: Brief educational treatment
Participants will receive one session of diagnostic feedback, recommendations for continued treatment, and crisis intervention as needed.
|
Thorough diagnostic assessment by a study evaluator, separate evaluation by a child psychiatrist, feedback session with parents and child, and provision of reading materials pertinent to managing childhood mood disorders.
Ongoing medication management and crisis-oriented family sessions will be available as needed.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Changes in symptoms and functioning of at-risk children, as defined by depression and mania scores and psychiatric status on the Adolescent Longitudinal Interval Follow-up Evaluation (A-LIFE)
Time Frame: Measured every 4 months for 1 year
|
Measured every 4 months for 1 year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Delayed onset of first manic, mixed, or hypomanic episode, measured on the A-LIFE
Time Frame: Measured every 4 months for 1 year
|
Measured every 4 months for 1 year
|
Scores on the Child Depression Rating Scale
Time Frame: Measured every 4 months for 1 year
|
Measured every 4 months for 1 year
|
Scores on the Young Mania Rating Scale
Time Frame: Measured every 4 months for 1 year
|
Measured every 4 months for 1 year
|
Parental mood and distress, as measured by the Beck Depression Inventory, Symptom Checklist
Time Frame: Measured every 4 months for 1 year
|
Measured every 4 months for 1 year
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: David J. Miklowitz, PhD, University of Colorado, Boulder
Publications and helpful links
General Publications
- Miklowitz DJ, Chang KD. Prevention of bipolar disorder in at-risk children: theoretical assumptions and empirical foundations. Dev Psychopathol. 2008 Summer;20(3):881-97. doi: 10.1017/S0954579408000424.
- Chang K, Howe M, Gallelli K, Miklowitz D. Prevention of pediatric bipolar disorder: integration of neurobiological and psychosocial processes. Ann N Y Acad Sci. 2006 Dec;1094:235-47. doi: 10.1196/annals.1376.026.
- Miklowitz DJ, Schneck CD, Singh MK, Taylor DO, George EL, Cosgrove VE, Howe ME, Dickinson LM, Garber J, Chang KD. Early intervention for symptomatic youth at risk for bipolar disorder: a randomized trial of family-focused therapy. J Am Acad Child Adolesc Psychiatry. 2013 Feb;52(2):121-31. doi: 10.1016/j.jaac.2012.10.007. Epub 2013 Jan 2.
- Schneck CD, Chang KD, Singh MK, DelBello MP, Miklowitz DJ. A Pharmacologic Algorithm for Youth Who Are at High Risk for Bipolar Disorder. J Child Adolesc Psychopharmacol. 2017 Nov;27(9):796-805. doi: 10.1089/cap.2017.0035. Epub 2017 Jul 21.
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R34MH077856 (U.S. NIH Grant/Contract)
- DSIR 84-CTS (Division of Services and Intervention Research)
- 5R34MH077856 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bipolar Disorder
-
ProgenaBiomeRecruitingBipolar Disorder | Bipolar I Disorder | Bipolar II Disorder | Bipolar Type I Disorder | Bipolar Disorder Mild | Bipolar Disorder Moderate | Bipolar Disorder SevereUnited States
-
Rush University Medical CenterThe Ryan Licht Sang Bipolar FoundationCompletedBipolar Disorder | Bipolar Depression | Bipolar I Disorder | Bipolar Disorder I | Bipolar Affective DisorderUnited States
-
University of PittsburghNational Alliance for Research on Schizophrenia and DepressionCompletedBipolar I Disorder | Bipolar II Disorder | Bipolar Disorder NOSUnited States
-
Region StockholmKarolinska InstitutetRecruitingBipolar Disorder | Bipolar Depression | Bipolar I Disorder | Bipolar II Disorder | Bipolar Affective Disorder; Remission in | Bipolar Affective Disorder, Currently Depressed, ModerateSweden
-
Hospital de Clinicas de Porto AlegreFederal University of Rio Grande do Sul; Hospital Moinhos de VentoActive, not recruitingBipolar Disorder | Bipolar Depression | Major Depressive Disorder | Bipolar I Disorder | Affective Disorder | Bipolar II DisorderBrazil
-
Mayo ClinicCompletedMajor Depressive Disorder, Bipolar I and Bipolar IIUnited States
-
Medical University of South CarolinaMilken InstituteCompletedBipolar Disorder | Bipolar I Disorder | Bipolar II DisorderUnited States
-
University Hospital, Strasbourg, FranceUnknownBipolar Disorder I | Bipolar Disorder II | Rapid Cycling Bipolar Disorder(DSM-IV-TR)France
-
Myriad Genetic Laboratories, Inc.University of MinnesotaCompletedMajor Depressive Disorder, Bipolar I and Bipolar IIUnited States
-
Universiteit AntwerpenUniversitair Ziekenhuis BrusselUnknownDepression | Mood Disorders | Bipolar Disorder | Bipolar Depression | Mental Disorder | Bipolar I Disorder | Bipolar II DisorderBelgium
Clinical Trials on Family-focused therapy
-
Dokuz Eylul UniversityCompletedBipolar Disorder | Psychosis | Family Relations | Mental Disorder in AdolescenceTurkey
-
University Hospital, MontpellierTerminated
-
Stanford UniversityUniversity of ChicagoCompleted
-
University of California, Los AngelesNational Institute of Mental Health (NIMH)CompletedPsychosisUnited States, Canada
-
VU University of AmsterdamUtrecht UniversityRecruiting
-
University of GuelphRecruitingDepression | Anxiety | Behavior ProblemCanada
-
University of California, Los AngelesNational Institute of Mental Health (NIMH)CompletedGeneralized Anxiety Disorder | Social Phobia | Separation Anxiety DisorderUnited States
-
University of California, Los AngelesStanford University; University of Colorado, BoulderCompletedBipolar Disorder | Major Depressive DisorderUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Monash University; Beth Israel Medical Center; Calvary Hospital, Bronx, NYActive, not recruiting
-
Sunnybrook Health Sciences CentreTerminated